NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Napco Security Technologies, Inc. (NASDAQ: NSSC).Shareholders who purchased shares of NSSC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/napco-security-technologies-inc-loss-submission-form/?id=151911&from=4CL ...

NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NET Power, Inc. (NYSE: NPWR).Shareholders who purchased shares of NPWR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/net-power-inc-loss-submission-form/?id=151910&from=4CLASS PERIOD: June 9, 2023 to March 7, 2 ...

NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Civitas Resources, Inc. (NYSE: CIVI).Shareholders who purchased shares of CIVI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/civitas-resources-loss-submission-form/?id=151914&from=4CLASS PERIOD: February 27, 2 ...

Core Viewpoint - Zenas BioPharma, Inc. is facing a class action lawsuit due to allegations of materially false and misleading statements regarding its financial status and operational funding during its initial public offering in September 2024 [2]. Group 1: Allegations - The complaint claims that Zenas BioPharma overstated its ability to fund operations with existing cash and expected net proceeds from the IPO [2]. - It is alleged that the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Class Action Details - The class period for the lawsuit includes shareholders who purchased ZBIO securities during the time of the IPO registration statement [1]. - Shareholders are encouraged to register for the class action by June 16, 2025, to potentially become lead plaintiffs [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - Iovance Biotherapeutics, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth potential while failing to meet revenue expectations, leading to a significant drop in stock price [1][2]. Summary by Sections Allegations - The lawsuit claims that during the class period from May 9, 2024, to May 8, 2025, Iovance made overly positive statements while concealing material adverse facts about its ability to generate demand for its treatments [1]. - The company announced a reduction in revenue guidance for fiscal year 2024, attributing this to maintenance issues, lower-than-expected Proleukin sales, and a variable pace in treatment initiation [1]. Financial Impact - Following the announcement of lowered guidance, Iovance's stock price plummeted from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025, marking a decline of approximately 44.795% in one day [1]. Next Steps for Shareholders - Shareholders who purchased IOVA shares during the specified class period are encouraged to register for the class action by July 14, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [3].

NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BigBear.ai Holdings, Inc. (NYSE: BBAI).Shareholders who purchased shares of BBAI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/bigbear-ai-holdings-inc-loss-submission-form/?id=151907&from=4CLASS PERIOD: March ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Strategy Incorporated regarding a class action lawsuit related to misleading statements about the company's bitcoin investment strategy and treasury operations [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from April 30, 2024, to April 4, 2025 [2]. - Allegations include that the company overstated the anticipated profitability of its bitcoin-focused strategy and understated the risks associated with bitcoin's volatility [2]. - The deadline for shareholders to register for the class action is July 15, 2025, and there is no cost to participate [3]. Group 2: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered due to deceit and illegal business practices [4]. - The firm is committed to ensuring companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [4].

Core Points - The Gross Law Firm has issued a notice to shareholders of Red Cat Holdings, Inc. regarding a class action lawsuit for shareholders who purchased shares during the class period from March 18, 2022, to January 15, 2025 [1] - Allegations include that the company overstated the production capacity of its Salt Lake City Facility and the value of the U.S. Army's Short Range Reconnaissance Program contract, leading to materially false and misleading public statements [1] - The deadline for shareholders to register for the class action and seek lead plaintiff status is July 22, 2025 [2] Company Information - Red Cat Holdings, Inc. is facing allegations of issuing materially false and misleading statements regarding its production capacity and contract values, which may have led to artificial inflation of its stock [1][3] - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to the company's alleged deceitful practices [3] Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates on the case [2] - Participation in the case incurs no cost or obligation for shareholders [2]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of West Pharmaceutical Services, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from February 16, 2023, to February 12, 2025 [1]. Group 1: Allegations - The complaint alleges that West Pharmaceutical Services claimed strong visibility into customer demand while actually experiencing significant destocking in its high-margin HVP portfolio [1]. - The SmartDose device, positioned as a high-margin growth product, was found to be dilutive to profit margins due to operational inefficiencies [1]. - Margin pressures from these issues raised the risk of costly restructuring activities, including exiting continuous glucose monitoring contracts with longstanding customers [1]. - Positive statements made by the defendants regarding the company's business and prospects were deemed materially false or misleading [1]. Group 2: Class Action Details - Shareholders who purchased shares of WST during the specified class period are encouraged to register for the class action, with a deadline of July 7, 2025, to seek lead plaintiff status [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UroGen Pharma Ltd. (NASDAQ: URGN).Shareholders who purchased shares of URGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/urogen-pharma-ltd-loss-submission-form/?id=151926&from=4CLASS PERIOD: July 27, 2023 to ...